CENTRAL ADMIXTURE PHARMACY SERVICES, INC

Central Admixture Pharmacy Services, Inc. specializes in the compounding and sterile preparation of patient-specific intravenous therapies, including total parenteral nutrition (TPN), lipid emulsions, cardioplegia solutions, and other complex admixtures under 503A and 503B regulatory frameworks. The company operates as a high-reliability pharmaceutical manufacturing facility, delivering just-in-time, sterile compounded products that meet USP <797> and <800> standards for safety and efficacy. Their technical expertise spans aseptic processing, automated compounding systems, batch traceability, and customized formulation development for acute and long-term care patients, with a demonstrated focus on institutional and military healthcare environments requiring precision dosing and stringent contamination control. The contractor maintains deep, sustained relationships with the Department of Veterans Affairs, providing mission-critical compounded IV therapies for VA medical centers nationwide, particularly for nutritional support and cardiac surgical needs. They also serve the Department of Defense with sterile admixture services for inpatient care and the Department of Health and Human Services through the procurement of compounded pharmaceuticals for federal health programs. Their contract patterns reflect long-term, recurring partnerships centered on reliable, high-volume sterile product delivery. Operating under NAICS 325412, the company is positioned as a specialized pharmaceutical compounding manufacturer rather than a retail pharmacy, serving the institutional healthcare supply chain. Their market focus is exclusively on complex, non-sterile-to-sterile transition products used in hospital and clinical settings, distinguishing them from standard drug distributors. As a 2L entity headquartered in Irvine, California, Central Admixture Pharmacy Services, Inc. functions as a scalable, federally compliant manufacturing partner without current federal certifications. Their geographic footprint supports nationwide distribution to federal medical facilities, with operational infrastructure engineered for regulatory compliance, cold chain logistics, and real-time order fulfillment in high-acuity care environments.